Temporal linguistic shifts in oncology randomized controlled trials following large language model availability: A corpus analysis of 21,392 publications
European Journal of Cancer · 2026-09 · 245 · 116963
DOI: 10.1016/j.ejca.2026.116963 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-09. Verfasst von Amina Silva und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Brock University, St. Catharines, St. Catharines, Ontario, Canada. Electronic address: asilva@brocku.ca. Hauptthemen laut MEDLINE: Large Language Models, Randomized Controlled Trials as Topic, Medical Oncology, Linguistics. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, Brock University, St. Catharines, St. Catharines, Ontario, Canada. Electronic address: asilva@brocku.ca.
- School of Nursing, Brock University, St. Catharines, St. Catharines, Ontario, Canada. Electronic address: vsilvaesilva@brocku.ca.
Zitieren
APA
Silva, A., & E Silva, V. S. (2026). Temporal linguistic shifts in oncology randomized controlled trials following large language model availability: A corpus analysis of 21,392 publications. European Journal of Cancer, 245, 116963. https://doi.org/10.1016/j.ejca.2026.116963
Vancouver
Silva A, E Silva VS. Temporal linguistic shifts in oncology randomized controlled trials following large language model availability: A corpus analysis of 21,392 publications. European Journal of Cancer. 2026;245:116963. doi:10.1016/j.ejca.2026.116963
BibTeX
@article{Silva2026,
author = {Silva, Amina and E Silva, Vanessa Silva},
title = {Temporal linguistic shifts in oncology randomized controlled trials following large language model availability: A corpus analysis of 21,392 publications},
journal = {European Journal of Cancer},
year = {2026},
volume = {245},
pages = {116963},
doi = {10.1016/j.ejca.2026.116963}
}
EUVIMED